Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial

Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial

Purpose. The present prospective randomized adjuvant trial was carried out to compare the toxicity, feasibility and efficacy of augmented chemotherapy added to hyperfractionated accelerated radiotherapy after wide or marginal resection of grade 2 and grade 3 soft...

Full description

Bibliographic Details
Main Authors: Thomas Brodowicz, Eva Schwameis, Joachim Widder, Gabriele Amann, Christoph Wiltschke, Martin Dominkus, Reinhard Windhager, Peter Ritschl, Richard Pötter, Rainer Kotz, Christoph C. Zielinski
Format: Article
Language:English
Published: Hindawi Limited 2000-01-01
Series:Sarcoma
Online Access:http://dx.doi.org/10.1155/2000/126837
id doaj-309cd5c797d24eefa90d996c379a47a3
record_format Article
spelling doaj-309cd5c797d24eefa90d996c379a47a32020-11-24T21:32:43ZengHindawi LimitedSarcoma1357-714X1369-16432000-01-014415116010.1155/2000/126837Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility TrialThomas Brodowicz0Eva Schwameis1Joachim Widder2Gabriele Amann3Christoph Wiltschke4Martin Dominkus5Reinhard Windhager6Peter Ritschl7Richard Pötter8Rainer Kotz9Christoph C. Zielinski10Clinical Division of Oncology, Vienna, AustriaDepartment of Orthopedic Surgery, Vienna, AustriaDepartment of Radiotherapy and Radiobiology, Vienna, AustriaDepartment of Clinical Pathology, University Hospital, Vienna, AustriaClinical Division of Oncology, Vienna, AustriaDepartment of Orthopedic Surgery, Vienna, AustriaDepartment of Orthopedic Surgery, Vienna, AustriaDepartment of Orthopedic Surgery, Orthopedic Hospital Gersthof, Vienna, AustriaDepartment of Radiotherapy and Radiobiology, Vienna, AustriaDepartment of Orthopedic Surgery, Vienna, AustriaClinical Division of Oncology, Vienna, AustriaPurpose. The present prospective randomized adjuvant trial was carried out to compare the toxicity, feasibility and efficacy of augmented chemotherapy added to hyperfractionated accelerated radiotherapy after wide or marginal resection of grade 2 and grade 3 soft tissue sarcoma (STS).http://dx.doi.org/10.1155/2000/126837
collection DOAJ
language English
format Article
sources DOAJ
author Thomas Brodowicz
Eva Schwameis
Joachim Widder
Gabriele Amann
Christoph Wiltschke
Martin Dominkus
Reinhard Windhager
Peter Ritschl
Richard Pötter
Rainer Kotz
Christoph C. Zielinski
spellingShingle Thomas Brodowicz
Eva Schwameis
Joachim Widder
Gabriele Amann
Christoph Wiltschke
Martin Dominkus
Reinhard Windhager
Peter Ritschl
Richard Pötter
Rainer Kotz
Christoph C. Zielinski
Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial
Sarcoma
author_facet Thomas Brodowicz
Eva Schwameis
Joachim Widder
Gabriele Amann
Christoph Wiltschke
Martin Dominkus
Reinhard Windhager
Peter Ritschl
Richard Pötter
Rainer Kotz
Christoph C. Zielinski
author_sort Thomas Brodowicz
title Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial
title_short Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial
title_full Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial
title_fullStr Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial
title_full_unstemmed Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial
title_sort intensified adjuvant ifadic chemotherapy for adult soft tissue sarcoma: a prospective randomized feasibility trial
publisher Hindawi Limited
series Sarcoma
issn 1357-714X
1369-1643
publishDate 2000-01-01
description Purpose. The present prospective randomized adjuvant trial was carried out to compare the toxicity, feasibility and efficacy of augmented chemotherapy added to hyperfractionated accelerated radiotherapy after wide or marginal resection of grade 2 and grade 3 soft tissue sarcoma (STS).
url http://dx.doi.org/10.1155/2000/126837
work_keys_str_mv AT thomasbrodowicz intensifiedadjuvantifadicchemotherapyforadultsofttissuesarcomaaprospectiverandomizedfeasibilitytrial
AT evaschwameis intensifiedadjuvantifadicchemotherapyforadultsofttissuesarcomaaprospectiverandomizedfeasibilitytrial
AT joachimwidder intensifiedadjuvantifadicchemotherapyforadultsofttissuesarcomaaprospectiverandomizedfeasibilitytrial
AT gabrieleamann intensifiedadjuvantifadicchemotherapyforadultsofttissuesarcomaaprospectiverandomizedfeasibilitytrial
AT christophwiltschke intensifiedadjuvantifadicchemotherapyforadultsofttissuesarcomaaprospectiverandomizedfeasibilitytrial
AT martindominkus intensifiedadjuvantifadicchemotherapyforadultsofttissuesarcomaaprospectiverandomizedfeasibilitytrial
AT reinhardwindhager intensifiedadjuvantifadicchemotherapyforadultsofttissuesarcomaaprospectiverandomizedfeasibilitytrial
AT peterritschl intensifiedadjuvantifadicchemotherapyforadultsofttissuesarcomaaprospectiverandomizedfeasibilitytrial
AT richardpotter intensifiedadjuvantifadicchemotherapyforadultsofttissuesarcomaaprospectiverandomizedfeasibilitytrial
AT rainerkotz intensifiedadjuvantifadicchemotherapyforadultsofttissuesarcomaaprospectiverandomizedfeasibilitytrial
AT christophczielinski intensifiedadjuvantifadicchemotherapyforadultsofttissuesarcomaaprospectiverandomizedfeasibilitytrial
_version_ 1725956337537384448

Similar Items